1.Clinical effect of Shenfu injection combined with glucocorticoid on patients with acute left heart failure complicated with bronchospasm.
Nengfeng ZHANG ; Zhifang MA ; Naiquan YANG ; Xu WANG
Chinese Critical Care Medicine 2023;35(12):1298-1303
OBJECTIVE:
To investigate the clinical effect of Shenfu injection combined with glucocorticoid in the treatment of acute left heart failure complicated with bronchospasm.
METHODS:
A prospective study was conducted.Ninety patients with acute left heart failure complicated with bronchospasm admitted to Huai'an Second People's Hospital from January 2021 to July 2022 were selected and divided into conventional treatment group, hormone therapy group and combined treatment group according to random number table method, with 30 cases in each group. All patients in the 3 groups received basic Western medicine treatment. On this basis, the conventional treatment group was given 0.25-0.50 g aminophylline injection plus 5% glucose injection or 0.9% sodium chloride injection (diabetes patients) 100 mL slow intravenous infusion, 1-2 times a day. In the hormone treatment group, 1 mg of budesonide suspension for inhalation was diluted to 2 mL by 0.9% sodium chloride injection, twice a day, and applied until 48 hours after the pulmonary wheezing disappeared. The combined treatment group was given glucocorticoid combined with Shenfu injection 80 mL plus 5% glucose injection or 0.9% sodium chloride injection (diabetes patients) 250 mL intravenously, once a day. All treated for 1 week. The general data, traditional Chinese medicine (TCM) syndrome score, TCM syndrone efficacy index, acute left heart failure efficacy, bronchospasm efficacy, systolic blood pressure (SBP), mean arterial pressure (MAP), serum N-terminal pro-brain natriuretic peptide (NT-proBNP) level and safety of the 3 groups were compared. The patients were followed up for 6 months, and the mortality and re-hospitalization rate of the 3 groups were recorded.
RESULTS:
Among the 90 patients, a total of 83 patients completed the study, excluding the cases dropped due to death and other reasons. There were 29 cases in the combined treatment group, 25 cases in the hormone therapy group and 29 cases in the conventional treatment group. There were no significant differences in age, gender, course of disease, and previous history (history of diabetes, history of hypertension, history of hyperlipidemia) among the 3 groups. Therefore, they were comparable. The difference of TCM syndrome score before and after treatment, TCM syndrome efficacy index of combined treatment group and hormone therapy group were higher than those of conventional treatment group [difference of TCM syndrome score: 15.14±5.74, 13.24±5.75 vs. 10.62±5.87, TCM syndrome efficacy index: (67.84±14.31)%, (59.94±14.26)% vs. (48.92±16.74)%, all P < 0.05], and the difference of TCM syndrome score and TCM syndrome efficacy index of combined treatment group were higher than those of hormone treatment group (both P < 0.05). The total effective rate of acute left heart failure and bronchospasm in the combined treatment group was significantly higher than that in the conventional treatment group (total effective rate of acute left heart failure: 96.55% vs. 75.86%, total effective rate of bronchospasm: 93.10% vs. 65.52%, both P < 0.05). The difference of serum NT-proBNP before and after treatment in combination therapy group and hormone therapy group was significantly higher than that in conventional treatment group (ng/L: 7 922.86±5 220.31, 7 314.92±4 450.28 vs. 4 644.79±3 388.23, all P < 0.05), and the difference of serum NT-proBNP before and after treatment in the combined treatment group was significantly higher than that in the hormone treatment group (P < 0.05). There were no significant differences in SBP difference, MAP difference, mortality and re-hospitalization rate among the 3 groups. No adverse reactions occurred in the 3 groups during treatment.
CONCLUSIONS
Shenfu injection combined with glucocorticoid is effective in the treatment of patients with acute left heart failure complicated with bronchospasm. It is superior to glucocorticoid and aminophylline in relieving bronchospasm, reducing NT-proBNP level and improving total effective rate, and has good prognosis and safety.
Humans
;
Glucocorticoids/therapeutic use*
;
Bronchial Spasm
;
Prospective Studies
;
Aminophylline/therapeutic use*
;
Sodium Chloride/therapeutic use*
;
Natriuretic Peptide, Brain
;
Peptide Fragments
;
Heart Failure/drug therapy*
;
Diabetes Mellitus
;
Glucose
2.Severe Anaphylaxis without Key Signs Such as Urticaria and Bronchospasm Suspected to Be Induced by Rocuronium
Soonchunhyang Medical Science 2019;25(1):76-79
Perioperative hypersensitivity reaction have been reported to have a variable degree of the incidence from differ countries and to be 1/353–18,600 approximately and its mortality has been reported to be 4%–4.76% in the United States and Japan, respectively. A 65-year-old male patient with hypertension, rheumatoid arthritis, and history of amoxicillin allergy was scheduled for laparoscopic radical prostatectomy due to prostate cancer. Lidocaine, propofol, and rocuronium were administered sequentially to induce general anesthesia. Twenty minutes after the rocuronium administration, severe hypotension and tachycardia developed. But key signs of hypersensitivity such as urticaria and bronchospasm were not appeared. The operation was canceled and we evaluated the cause of severe hypotension and could confirm hypersensitivity for rocuronium with intradermal test after 4 weeks.
Aged
;
Amoxicillin
;
Anaphylaxis
;
Anesthesia, General
;
Arthritis, Rheumatoid
;
Bronchial Spasm
;
Humans
;
Hypersensitivity
;
Hypertension
;
Hypotension
;
Incidence
;
Intradermal Tests
;
Japan
;
Lidocaine
;
Male
;
Mortality
;
Propofol
;
Prostatectomy
;
Prostatic Neoplasms
;
Tachycardia
;
United States
;
Urticaria
3.The KAAACI Standardization Committee Report on the procedure and application of the bronchial provocation tests
Kyung Hwan LIM ; Min Hye KIM ; Min Suk YANG ; Woo Jung SONG ; Jae Woo JUNG ; Jeongmin LEE ; Dong In SUH ; Yoo Seob SHIN ; Jae Woo KWON ; Sae Hoon KIM ; Sang Heon KIM ; Byung Jae LEE ; Sang Heon CHO ;
Allergy, Asthma & Respiratory Disease 2018;6(1):14-25
Bronchial provocation tests are of value in the evaluation of airway hyperresponsiveness. Nonspecific bronchial challenge (methacholine, mannitol, exercise, etc.) is used when the symptoms, physical examination, and measurements of pulmonary function are unremarkable in the diagnosis of asthma, when a patient is suspected of having occupational asthma or exercise-induced bronchoconstriction (EIB), and when a screening test for asthma or EIB is required for some occupational groups in whom bronchospasm would pose an unacceptable hazard. Methacholine inhalation challenge is most widely used pharmacologic challenge and highly sensitive. For appropriate interpretation of the results of methacholine provocation, it is important to perform the test with the standardized protocol and to recognize that inhalation methods significantly influence the sensitivity of the procedure. Indirect challenges (e.g., mannitol and exercise) correlate with airway inflammation and are more specific but less sensitive for asthma. Indirect provocation tests are used to confirm asthma, to differentiate asthma from other airway diseases, and to evaluate EIB.
Asthma
;
Asthma, Occupational
;
Bronchial Provocation Tests
;
Bronchial Spasm
;
Bronchoconstriction
;
Diagnosis
;
Exercise Test
;
Humans
;
Inflammation
;
Inhalation
;
Mannitol
;
Mass Screening
;
Methacholine Chloride
;
Occupational Groups
;
Physical Examination
4.Residential NO₂ exposure is associated with urgent healthcare use in a thunderstorm asthma cohort
Vivien Wai Yun LAI ; Gayan BOWATTE ; Luke David KNIBBS ; Kanishka RANGAMUWA ; Alan YOUNG ; Shyamali DHARMAGE ; Francis THIEN
Asia Pacific Allergy 2018;8(4):e33-
BACKGROUND: There is increasing interest in the role of traffic-related air pollution (TRAP) in allergic airway diseases. Few studies investigate the relationship between TRAP exposure and acute exacerbations of asthma. OBJECTIVE: The 2016 Melbourne thunderstorm asthma epidemic provided an opportunity to investigate the relationship between proxies of TRAP exposure and asthma exacerbation requiring urgent healthcare in the previous 12 months. METHODS: Current asthmatics who presented to the 3 Emergency Departments of Melbourne's second-largest health service with epidemic thunderstorm asthma in November 2016 were identified and completed a standard questionnaire. Their residential addresses were geocoded and the annual average nitrogen dioxide (NO2) exposure for each patient was assigned using a validated satellite-based land use regression model. Residential distance to the nearest major road was calculated using ArcGIS. Multivariate logistic regression was used to investigate the relationship between each TRAP proxy and healthcare use, adjusting for potential confounders. RESULTS: From 263 thunderstorm asthma patients, 88 patients identified with current asthma were analysed. Those with higher mean annual residential NO2 exposure had greater odds of urgent healthcare use in the previous year (odds ratio [OR], 3.45 per one interquartile-range increase; 95% confidence interval [CI], 1.31–9.10; p = 0.01), however distance from major road (OR, 0.95 per 100-m increase; 95% CI, 0.80–1.13; p = 0.57) and living < 200 m from a major road (OR, 1.47; 95% CI, 0.29–7.45; p = 0.64) were not significantly associated. CONCLUSION: In current asthmatics who presented during an epidemic thunderstorm asthma event, greater exposure to residential NO2 was significantly associated with greater odds of asthma exacerbations requiring urgent healthcare in the previous 12 months.
Air Pollution
;
Asthma
;
Bronchial Spasm
;
Cohort Studies
;
Delivery of Health Care
;
Emergency Service, Hospital
;
Environmental Exposure
;
Environmental Pollutants
;
Health Services
;
Humans
;
Hypersensitivity
;
Logistic Models
;
Nitrogen Dioxide
;
Proxy
5.Anaphylaxis occurred immediately after prophylactic antibiotics injection with negative intradermal skin test during laparoscopic cholecystectomy.
Hyung Joo JEONG ; Hsi Chiang KUNG ; Tae Woo PARK ; Dong Hee KANG ; Yu Som SHIN ; Ju Deok KIM
Kosin Medical Journal 2018;33(2):245-251
Prophylactic antibiotics that are used to prevent post-operative infection can commonly cause anaphylactic reactions during anesthesia. It is therefore necessary to perform a skin test before antibiotics are administered in order to diagnose and prevent anaphylactic reactions. However, the results of the antibiotic skin test can differ according to the drug, dose, and reagent concentration. We report a case of anaphylactic shock with bronchospasm and cardiovascular collapse immediately following administration of the prophylactic cefazedone after induction of general anesthesia for laparoscopic cholecystectomy.
Anaphylaxis*
;
Anesthesia
;
Anesthesia, General
;
Anti-Bacterial Agents*
;
Bronchial Spasm
;
Cholecystectomy, Laparoscopic*
;
Intradermal Tests
;
Shock
;
Skin Tests*
;
Skin*
6.Postoperative negative pressure pulmonary edema following repetitive laryngospasm even after reversal of neuromuscular blockade by sugammadex: a case report.
Ji Hyeon LEE ; Jae Ho LEE ; Min Hyun LEE ; Hyun Oh CHO ; Soon Eun PARK
Korean Journal of Anesthesiology 2017;70(1):95-99
Laryngospasm, an occlusion of the glottis, can occur at any time during anesthesia, and is associated with serious perioperative complications such as hypoxia, hypercabia, aspiration, bronchospasm, arrhythmia, prolonged recovery, cardiac collapse, and eventually catastrophic death. Importantly, postoperative negative pressure pulmonary edema (NPPE) is a rare, but well described life-threatening complication related to acute and chronic upper airway obstruction. Sugammadex well known for affirmatively reducing the postoperative pulmonary complications associated with residual neuromuscular blockade may have an indirect role in triggering the negative intrathoracic pressure by raising a rapid and efficacious respiratory muscle strength in acute upper airway obstruction. Herein, we report a case of postoperative NPPE following repetitive laryngospasm even after reversal of rocuronium-induced neuromuscular blockade using sugammadex.
Airway Obstruction
;
Anesthesia
;
Anoxia
;
Arrhythmias, Cardiac
;
Bronchial Spasm
;
Delayed Emergence from Anesthesia
;
Glottis
;
Laryngismus*
;
Neuromuscular Blockade*
;
Pulmonary Edema*
;
Respiratory Muscles
7.Immediate hypersensitivity reaction to steroids: a case report.
Eun Ji KIM ; Kyoung Hee SOHN ; Jin LEE ; Dong Yoon KANG ; Ju Yeun LEE ; Hye Ryun KANG
Allergy, Asthma & Respiratory Disease 2017;5(3):165-168
Steroids are widely used for the treatment of a variety of diseases, including autoimmune and allergic diseases. Immediate hypersensitivity reactions can occur within 1 hour after administration of steroids and are regarded as IgE-mediated hypersensitivity presenting as urticaria, angioedema, bronchospasm, and anaphylaxis. Steroid hypersensitivity is rare, but can be life-threatening. Therefore, it is important to find implicated drugs and to choose safe alternative agents. A 44-year-old female was diagnosed with steroid hypersensitivity after intralesional steroid injection. She underwent a skin prick test and an intradermal test for methylprednisolone, triamcinolone, hydrocortisone, and dexamethasone. The results were positive to triamcinolone and methylprednisolone. The patient was educated to avoid culprit agents in order to prevent recurrence. Herein, we report a rare case of steroid hypersensitivity that showed positive reactions to triamcinolone and methylprednisolone. A review of the literature for steroid hypersensitivity is also provided.
Adult
;
Anaphylaxis
;
Angioedema
;
Bronchial Spasm
;
Dexamethasone
;
Drug Hypersensitivity
;
Female
;
Humans
;
Hydrocortisone
;
Hypersensitivity
;
Hypersensitivity, Immediate*
;
Intradermal Tests
;
Methylprednisolone
;
Recurrence
;
Skin
;
Skin Tests
;
Steroids*
;
Triamcinolone
;
Urticaria
8.The effect of tulobuterol patches on the respiratory system after endotracheal intubation.
Do Won LEE ; Eun Soo KIM ; Wang Seok DO ; Han Bit LEE ; Eun Jung KIM ; Cheul Hong KIM
Journal of Dental Anesthesia and Pain Medicine 2017;17(4):265-270
BACKGROUND: Endotracheal intubation during anesthesia induction may increase airway resistance (R(aw)) and decrease dynamic lung compliance (Cdyn). We hypothesized that prophylactic treatment with a transdermal β2-agonist tulobuterol patch (TP) would help to reduce the risk of bronchospasm after placement of the endotracheal tube. METHODS: Eighty-two American Society of Anesthesiologists (ASA) category I or II adult patients showing obstructive patterns were divided randomly into a control and a TP group (n = 41 each). The night before surgery, a 2-mg TP was applied to patients in the TP group. Standard monitors were recorded, and target controlled infusion (TCI) with propofol and remifentanil was used for anesthesia induction and maintenance. Simultaneously, end-tidal carbon dioxide, R(aw), and Cdyn were determined at 5, 10, and 15 min intervals after endotracheal intubation. RESULTS: There was no significant difference in demographic data between the two groups. The TP group was associated with a lower R(aw) and a higher Cdyn, as compared to the control group. R(aw) was significantly lower at 10 min (P < 0.05) and 15 min (P < 0.01), and Cdyn was significantly higher at 5 min (P < 0.05) and 15 min (P < 0.01) in the TP group. A trend towards a lower R(aw) was observed showing a statistically significant difference 5 min after endotracheal intubation (P < 0.01) in each group. CONCLUSIONS: Prophylactic treatment with TP showed a bronchodilatory effect through suppressing an increase in R(aw) and a decrease in C(dyn) after anesthesia induction without severe adverse effects.
Adult
;
Airway Resistance
;
Anesthesia
;
Bronchial Spasm
;
Carbon Dioxide
;
Humans
;
Intubation, Intratracheal*
;
Lung Compliance
;
Propofol
;
Respiratory System*
9.Airway obstruction during general anesthesia in a premature infant suspecting bronchospasm and/or airway malacia: A case report.
Hyojung SEO ; Sangjin PARK ; Haemi LEE
Anesthesia and Pain Medicine 2017;12(2):147-150
Airway management is challenging during general anesthesia particularly in small infants. Airway obstruction is prone to occur in premature infants during general anesthesia due to several reasons. We report a case of airway obstruction occurred during the induction of general anesthesia in a 2-month-old infant. Several attempts at endotracheal intubation with positive pressure ventilation resulted in repeated patterns of no end-tidal carbon dioxide output after each trial of endotracheal intubation, but it was reappeared after extubation. However, anesthetic induction with self-respiration and gentle assistance with manual bagging led to a successful intubation. This case was explained by hydromechanics in a collapsible premature airway.
Airway Management
;
Airway Obstruction*
;
Anesthesia, General*
;
Bronchial Spasm*
;
Carbon Dioxide
;
Humans
;
Infant
;
Infant, Newborn
;
Infant, Premature*
;
Intubation
;
Intubation, Intratracheal
;
Positive-Pressure Respiration
10.The roles of mast cells in allergic inflammation and mast cell-related disorders.
Allergy, Asthma & Respiratory Disease 2017;5(5):248-255
Mast cells, which are major effector cells in allergic reactions, are found in the perivascular spaces of most tissues and contain pro-inflammatory and vasoactive mediators. These mediators are released after IgE receptor cross-linking induced by allergens or other stimuli, including anaphylatoxins (C3a and C5a), aggregated IgG, certain drugs, venoms, and physical stimuli (pressure and temperature changes), as well as cytokines and neuropeptides. The excess release of these mediators can cause variable allergic symptoms and signs, such as bronchospasm, itching, flushing, nausea, vomiting, diarrhea, abdominal pain, vascular instability, and anaphylaxis. Furthermore, mast cell disorders may involve either excessive proliferation of mast cells or abnormal mast cell reactivity. Mast cell disorders can be broadly divided into 3 types: primary, secondary, and idiopathic. All of these disorders present with signs and symptoms of mast cell activation and differ in severity and involvement of various organ systems. The best characterized primary disorder is mastocytosis. Systemic and cutaneous forms of the disease are well described. Secondary disorders include typical allergic diseases and some types of urticarial diseases. In this article, the biochemical characteristics of mast cells and the role of mast cells in allergic inflammation, as well as the classification, diagnosis, and management of mast cell-related disorders, will be reviewed.
Abdominal Pain
;
Allergens
;
Allergy and Immunology
;
Anaphylatoxins
;
Anaphylaxis
;
Bronchial Spasm
;
Classification
;
Cytokines
;
Diagnosis
;
Diarrhea
;
Flushing
;
Hypersensitivity
;
Immunoglobulin E
;
Immunoglobulin G
;
Inflammation*
;
Mast Cells*
;
Mastocytosis
;
Nausea
;
Neuropeptides
;
Pruritus
;
Venoms
;
Vomiting

Result Analysis
Print
Save
E-mail